In the news

News headlines are articles that reference ResMed's company, people, or business practices.

Advanced Search
  • July 30, 2018
    University of Washington

    A mobile technology conceived and researched at the University of Washington’s Paul G. Allen School of Computer Science & Engineering and UW Medicine designed to track breathing and body movements without requiring contact with the human body, has helped inspire the active sonar portion of the just-launched SleepScore mobile application, available worldwide to iOS and Android users.

  • July 12, 2018
    CNBC

    ResMed and Verily are investing an undisclosed amount in the as-yet-unnamed venture, and is focused on sleep apnea and other sleep breathing disorders. This is not the first time that Verily has partnered with a life sciences company for a joint venture: It is also working with Johnson & Johnson on an effort called Verb Surgical to develop a next-generation surgical robot.

  • June 15, 2018
    HME News

    ResMed and Xealth have launched a pilot project that allows primary care physicians at Providence St. Joseph Health to access data from CPAP devices right from their electronic medical record software.

  • Sleep Review logo
    June 3, 2018
    Sleep Review

    A new ResMed-funded retrospective study explores a potential factor of long-term adherence: mask resupply programs.

  • Mass Device logo
    May 21, 2018
    MassDevice

    ResMed today released data from two clinical analyses exploring combined home oxygen therapy and non-invasive ventilation therapy for patients with persistent hypercapnia following a life-threatening exacerbation of COPD, touting an increase in cost efficiency with the combined therapy.

Show 5102550100 per page
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages